HealthEquity, Inc. (NASDAQ:HQY) Director Sells $99,847.90 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Frank Corvino also recently made the following trade(s):

• On Tuesday, October 1st, Frank Corvino sold 1,247 shares of HealthEquity stock. The stock was sold at an average price of $80.26, for a total value of $100,084.22.

HealthEquity Stock Up 1.7 %

NASDAQ HQY traded up $1.62 during trading hours on Friday, hitting $98.82. 666,502 shares of the company were exchanged, compared to its average volume of 616,010. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.63 billion, a price-to-earnings ratio of 80.91, a PEG ratio of 1.36 and a beta of 0.52. The company has a 50 day moving average of $82.77 and a two-hundred day moving average of $80.31. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $99.57.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The company had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. Equities research analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Institutional Trading of HealthEquity

Several institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC acquired a new position in shares of HealthEquity in the 2nd quarter worth approximately $35,000. Paladin Wealth LLC acquired a new position in shares of HealthEquity during the 3rd quarter worth about $39,000. GAMMA Investing LLC raised its position in HealthEquity by 114.8% in the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after purchasing an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity in the second quarter valued at $73,000. Finally, 1620 Investment Advisors Inc. acquired a new stake in shares of HealthEquity during the 3rd quarter worth about $112,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

HQY has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America decreased their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. JMP Securities restated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Barrington Research reissued an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $103.83.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.